54 related articles for article (PubMed ID: 8343222)
1. Enhanced expression of the c-myc protooncogene in human intracranial meningiomas.
Kim JH; Lee SH; Cho KJ; Jang JJ; Hong SI; Lee JH
J Korean Med Sci; 1993 Feb; 8(1):68-72. PubMed ID: 8343222
[TBL] [Abstract][Full Text] [Related]
2. Enhanced expression of the sis and c-myc oncogenes in human meningiomas.
Kazumoto K; Tamura M; Hoshino H; Yuasa Y
J Neurosurg; 1990 May; 72(5):786-91. PubMed ID: 2182793
[TBL] [Abstract][Full Text] [Related]
3. BCR expression is decreased in meningiomas showing loss of heterozygosity of 22q within a new minimal deletion region.
Wozniak K; Piaskowski S; Gresner SM; Golanska E; Bieniek E; Bigoszewska K; Sikorska B; Szybka M; Kulczycka-Wojdala D; Zakrzewska M; Zawlik I; Papierz W; Stawski R; Jaskolski DJ; Och W; Sieruta M; Liberski PP; Rieske P
Cancer Genet Cytogenet; 2008 May; 183(1):14-20. PubMed ID: 18474292
[TBL] [Abstract][Full Text] [Related]
4. The molecular biology of hormone and growth factor receptors in meningiomas.
Black P; Carroll R; Zhang J
Acta Neurochir Suppl; 1996; 65():50-3. PubMed ID: 8738495
[TBL] [Abstract][Full Text] [Related]
5. Analysis of c-myc oncogene in human esophageal carcinoma: immunohistochemistry, in situ hybridization and northern and Southern blot studies.
Miyazaki S; Sasno H; Shiga K; Sawai T; Nishihira T; Okamoto H; Mori S
Anticancer Res; 1992; 12(5):1747-55. PubMed ID: 1444241
[TBL] [Abstract][Full Text] [Related]
6. Involvement of disregulated c-myc but not c-sis/PDGF in atypical and anaplastic meningiomas.
Nagashima G; Aoyagi M; Yamamoto S; Wakimoto H; Tamaki M; Yamamoto K; Fujimoto T; Hirakawa K
Clin Neurol Neurosurg; 2001 Apr; 103(1):13-8. PubMed ID: 11311470
[TBL] [Abstract][Full Text] [Related]
7. Altered expression of beta-catenin/E-cadherin in meningiomas.
Brunner EC; Romeike BF; Jung M; Comtesse N; Meese E
Histopathology; 2006 Aug; 49(2):178-87. PubMed ID: 16879395
[TBL] [Abstract][Full Text] [Related]
8. [Amplification of L-myc oncogene in malignant meningioma. Case report].
Jimbo T; Tsuboi K; Iwamura Y; Kaneko M; Nakagawa K; Nose T
Neurol Med Chir (Tokyo); 1991 Dec; 31(13):1040-4. PubMed ID: 1726240
[TBL] [Abstract][Full Text] [Related]
9. Loss of the Y chromosome in meningiomas. A molecular genetic approach.
Logan JA; Seizinger BR; Atkins L; Martuza RL
Cancer Genet Cytogenet; 1990 Mar; 45(1):41-7. PubMed ID: 2302684
[TBL] [Abstract][Full Text] [Related]
10. Biologic heterogeneity of angiomatous meningiomas.
Janowska K; Kordek R; Biernat W; Liberski PP; Krul W; Debiec-Rychter M
Pol J Pathol; 1998; 49(4):279-84. PubMed ID: 10323082
[TBL] [Abstract][Full Text] [Related]
11. Reduced expression of ELAVL4 in male meningioma patients.
Stawski R; Piaskowski S; Stoczynska-Fidelus E; Wozniak K; Bienkowski M; Zakrzewska M; Witusik-Perkowska M; Jaskolski DJ; Och W; Papierz W; Sikorska B; Rieske P; Liberski PP
Brain Tumor Pathol; 2013 Jul; 30(3):160-6. PubMed ID: 22965691
[TBL] [Abstract][Full Text] [Related]
12. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.
Boström J; Meyer-Puttlitz B; Wolter M; Blaschke B; Weber RG; Lichter P; Ichimura K; Collins VP; Reifenberger G
Am J Pathol; 2001 Aug; 159(2):661-9. PubMed ID: 11485924
[TBL] [Abstract][Full Text] [Related]
13. Loss of genes on the long arm of chromosome 22 in human meningiomas.
Okazaki M; Nishisho I; Tateishi H; Motomura K; Yamamoto M; Miki T; Hayakawa T; Takai S; Honjo T; Mori T
Mol Biol Med; 1988 Feb; 5(1):15-22. PubMed ID: 2897611
[TBL] [Abstract][Full Text] [Related]
14. Expression of the c-erbB-2-encoded oncoprotein and progesterone receptor in human meningiomas.
Schlegel J; Ullrich B; Stumm G; Gass P; Harwerth IM; Hynes NE; Kiessling M
Acta Neuropathol; 1993; 86(5):473-9. PubMed ID: 7906070
[TBL] [Abstract][Full Text] [Related]
15. Microarray-based analysis of spinal versus intracranial meningiomas: different clinical, biological, and genetic characteristics associated with distinct patterns of gene expression.
Sayagués JM; Tabernero MD; Maíllo A; Trelles O; Espinosa AB; Sarasquete ME; Merino M; Rasillo A; Vera JF; Santos-Briz A; de Alava E; Garcia-Macias MC; Orfao A
J Neuropathol Exp Neurol; 2006 May; 65(5):445-54. PubMed ID: 16772868
[TBL] [Abstract][Full Text] [Related]
16. Analysis of meningiomas by methylation- and transcription-based clonality assays.
Zhu J; Frosch MP; Busque L; Beggs AH; Dashner K; Gilliland DG; Black PM
Cancer Res; 1995 Sep; 55(17):3865-72. PubMed ID: 7641206
[TBL] [Abstract][Full Text] [Related]
17. The expression of disabled-2 is common reduced in meningiomas.
Zhang Z; Chen Y; Xie X; Tang J
Neurol India; 2014; 62(1):57-61. PubMed ID: 24608456
[TBL] [Abstract][Full Text] [Related]
18. Tight association of loss of merlin expression with loss of heterozygosity at chromosome 22q in sporadic meningiomas.
Ueki K; Wen-Bin C; Narita Y; Asai A; Kirino T
Cancer Res; 1999 Dec; 59(23):5995-8. PubMed ID: 10606247
[TBL] [Abstract][Full Text] [Related]
19. Molecular genetic analysis of chromosome 22 in 81 cases of meningioma.
Dumanski JP; Rouleau GA; Nordenskjöld M; Collins VP
Cancer Res; 1990 Sep; 50(18):5863-7. PubMed ID: 2393856
[TBL] [Abstract][Full Text] [Related]
20. 1p and 3p deletions in meningiomas without detectable aberrations of chromosome 22 identified by comparative genomic hybridization.
Carlson KM; Bruder C; Nordenskjöld M; Dumanski JP
Genes Chromosomes Cancer; 1997 Dec; 20(4):419-24. PubMed ID: 9408760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
